Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from May 2022.
Pharmaceuticals
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: COVID-19, Patents, and Trade Secrets COVID-19, Patents, and Trade Secrets
Has the global distribution of COVID-19 vaccines been impacted by patent rights? David Gindler and Jasper L. Tran argue that the story is complicated.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from April 2022.
-
Read more: Misleading, Coercive Language in Bills Barring Trans Youth Access to Gender Affirming Care Misleading, Coercive Language in Bills Barring Trans Youth Access to Gender Affirming Care
Don’t be fooled by the savior titles and biased “evidence;” these bills are neither compassionate nor protective.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from March 2022.
-
Read more: Small Doses of Psychedelics for Cluster Headaches Small Doses of Psychedelics for Cluster Headaches
One understudied condition for which small doses of psychedelic substances such as psilocybin may be beneficial is cluster headache.
-
Read more: Findings from the Microdose.me Study: A Large Scale Observational Study of Psychedelic Microdosing Findings from the Microdose.me Study: A Large Scale Observational Study of Psychedelic Microdosing
One primary aim of our study was to describe microdosing practices and motivations and consider how these factors vary across subgroups.
-
Read more: Safety First: Potential Heart Health Risks of Microdosing Safety First: Potential Heart Health Risks of Microdosing
Given the current evidence for psychedelic “microdosing,” the risks may outweigh the benefits for many people.
-
Read more: The Proposed TRIPS Compromise Risks Setting Several Bad Precedents The Proposed TRIPS Compromise Risks Setting Several Bad Precedents
The proposal introduces precedents that will be used to justify further narrowing of TRIPS flexibilities.
-
Read more: Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation
We are excited to welcome our inaugural group of affiliated researchers for the Project on Psychedelics Law and Regulation (POPLAR).
